Cargando…

Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor

PURPOSE: The role of platelets during myocardial ischemia/reperfusion (I/R) is ambivalent. They contribute to injury but also to cardioprotection. Repeated blood flow restriction and reperfusion in a tissue/organ remote from the heart (remote ischemic conditioning, RIC) reduce myocardial I/R injury...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieder, Helmut Raphael, Tsoumani, Maria, Andreadou, Ioanna, Schrör, Karsten, Heusch, Gerd, Kleinbongard, Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517043/ https://www.ncbi.nlm.nih.gov/pubmed/35595877 http://dx.doi.org/10.1007/s10557-022-07345-9

Ejemplares similares

Sex is no determinant of cardioprotection by ischemic preconditioning in rats, but ischemic/reperfused tissue mass is for remote ischemic preconditioning
por: Lieder, Helmut R., et al.
Publicado: (2019)

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes
por: Lieder, Helmut Raphael, et al.
Publicado: (2021)

Non-responsiveness to cardioprotection by ischaemic preconditioning in Ossabaw minipigs with genetic predisposition to, but without the phenotype of the metabolic syndrome
por: Kleinbongard, Petra, et al.
Publicado: (2022)

No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs
por: Kleinbongard, Petra, et al.
Publicado: (2023)

The platelet paradox of injury versus protection in myocardial infarction—has it been overlooked?
por: Kleinbongard, Petra, et al.
Publicado: (2021)

Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020)

Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning
por: Gedik, Nilguen, et al.
Publicado: (2016)

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

Cardioprotection by early metoprolol- attenuation of ischemic vs. reperfusion injury?
por: Kleinbongard, Petra
Publicado: (2020)

PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation
por: Andreadou, Ioanna, et al.
Publicado: (2020)

Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning
por: Hildebrandt, Heike A., et al.
Publicado: (2016)

Cardioprotection by Hypothyroidism Is Not Mediated by Favorable Hemodynamics—Role of Canonical Thyroid Hormone Receptor Alpha Signaling
por: Pape, Janina, et al.
Publicado: (2022)

Perspective: mitochondrial STAT3 in cardioprotection
por: Kleinbongard, Petra
Publicado: (2023)

A fresh look at coronary microembolization
por: Kleinbongard, Petra, et al.
Publicado: (2021)

Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization
por: Gedik, Nilgün, et al.
Publicado: (2017)

No Evidence for Activated Autophagy in Left Ventricular Myocardium at Early Reperfusion with Protection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting
por: Gedik, Nilgün, et al.
Publicado: (2014)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Larger infarct size but equal protection by ischemic conditioning in septum and anterior free wall of pigs with LAD occlusion
por: Skyschally, Andreas, et al.
Publicado: (2019)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
por: Johnson, Thomas W., et al.
Publicado: (2020)

Mitochondrial and Contractile Function of Human Right Atrial Tissue in Response to Remote Ischemic Conditioning
por: Kleinbongard, Petra, et al.
Publicado: (2018)

Aspirate from human stented saphenous vein grafts induces epicardial coronary vasoconstriction and impairs perfusion and left ventricular function in rat bioassay hearts with pharmacologically induced endothelial dysfunction
por: Lieder, Helmut R., et al.
Publicado: (2016)

Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
por: Joo, Hyung Joon, et al.
Publicado: (2018)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
por: Bøtker, Hans Erik, et al.
Publicado: (2018)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning
por: Gedik, Nilgün, et al.
Publicado: (2017)

Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart
por: Mittal, Dhiraj, et al.
Publicado: (2016)

Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
por: Traby, Ludwig, et al.
Publicado: (2019)

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial
por: Baos, Sarah, et al.
Publicado: (2017)

Perioperative Cardioprotection by Remote Ischemic Conditioning
por: Cho, Youn Joung, et al.
Publicado: (2019)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
por: Alexopoulos, Dimitrios, et al.
Publicado: (2015)

Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2013)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Aspirin/ticagrelor: Haemoperitoneum and hepatic subcapsular haematoma: 2 case reports
Publicado: (2021)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study
por: Kander, Thomas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hg3uej6gq6f3cuojdi02kd518i